IGF1R and neoplasm: Thus, it is possible that these tumor-initiating cells require the activation of HIF-1α/Notch/IGF-IR/Akt pathway, and may become sensitive to the antitumor effect of Notch inhibitors in combination with IGF-IR/Akt inhibitors.